KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 153 filers reported holding KURA ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $421,000 | -65.2% | 30,094 | -53.4% | 0.04% | -74.5% |
Q3 2021 | $1,209,000 | +292.5% | 64,542 | +336.6% | 0.14% | +208.5% |
Q2 2021 | $308,000 | -30.2% | 14,784 | -5.1% | 0.05% | -51.5% |
Q1 2021 | $441,000 | -46.7% | 15,584 | -38.4% | 0.10% | -62.7% |
Q4 2020 | $827,000 | – | 25,308 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |